3p25.3 microdeletion syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:435638Q93.5
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

3p25.3 microdeletion syndrome is a rare genetic condition caused by a small missing piece (deletion) of chromosome 3 at a specific location called 3p25.3. This region contains important genes that play a role in brain development and overall growth. Because these genes are missing, children with this syndrome typically experience developmental delays, intellectual disability, and distinctive facial features. Common facial features may include a broad forehead, widely spaced eyes, a flat nasal bridge, and a thin upper lip. Many children also have low muscle tone (hypotonia), which can affect their ability to sit, crawl, and walk on time. Some individuals may have behavioral challenges, including features of autism spectrum disorder or attention difficulties. Heart defects and other organ abnormalities have also been reported in some cases. The severity of symptoms can vary depending on the exact size of the deletion and which genes are affected. There is currently no cure for this condition, so treatment focuses on managing individual symptoms through therapies such as speech therapy, physical therapy, occupational therapy, and special education support. Early intervention services are very important to help children reach their full potential. Regular follow-up with a team of specialists is recommended to monitor development and address any medical concerns as they arise.

Also known as:

Key symptoms:

Developmental delaysIntellectual disabilityLow muscle tone (floppy muscles)Speech and language delaysDistinctive facial featuresWidely spaced eyesBroad foreheadFlat nasal bridgeThin upper lipBehavioral difficultiesFeatures of autism spectrum disorderFeeding difficulties in infancyShort stature or growth delaysHeart defects in some casesSeizures in some cases

Clinical phenotype terms (50)— hover any for plain English
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for 3p25.3 microdeletion syndrome.

View clinical trials →

No actively recruiting trials found for 3p25.3 microdeletion syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the 3p25.3 microdeletion syndrome community →

No specialists are currently listed for 3p25.3 microdeletion syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to 3p25.3 microdeletion syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open 3p25.3 microdeletion syndromeForum →

No community posts yet. Be the first to share your experience with 3p25.3 microdeletion syndrome.

Start the conversation →

Latest news about 3p25.3 microdeletion syndrome

No recent news articles for 3p25.3 microdeletion syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What is the exact size of my child's deletion, and which genes are affected?,Was this deletion inherited or did it happen spontaneously?,What therapies should we start right away, and how often?,Does my child need heart or other organ screening?,What developmental milestones should I watch for, and when should I be concerned?,Are there any clinical trials or research studies we could participate in?,What is the chance of this happening again in a future pregnancy?

Common questions about 3p25.3 microdeletion syndrome

What is 3p25.3 microdeletion syndrome?

3p25.3 microdeletion syndrome is a rare genetic condition caused by a small missing piece (deletion) of chromosome 3 at a specific location called 3p25.3. This region contains important genes that play a role in brain development and overall growth. Because these genes are missing, children with this syndrome typically experience developmental delays, intellectual disability, and distinctive facial features. Common facial features may include a broad forehead, widely spaced eyes, a flat nasal bridge, and a thin upper lip. Many children also have low muscle tone (hypotonia), which can affect th

How is 3p25.3 microdeletion syndrome inherited?

3p25.3 microdeletion syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does 3p25.3 microdeletion syndrome typically begin?

Typical onset of 3p25.3 microdeletion syndrome is neonatal. Age of onset can vary across affected individuals.